Also listed on Ono Pharmaceutical Co., Ltd., an earlier holder on the record. The recorded assignments below show how it moved.
Term ended Oct 24, 2026 · High confidence
20-year base term ended May 2, 2026
May 2, 2006
Oct 24, 2026
Jul 12, 2016
This patent's term runs 175 days past its 20-year base term on prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. Confidence: High. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts May 2, 2006, when application PCT/JP2006/309606, the earliest non-provisional in its chain, was filed (this one was filed Apr 3, 2014) | May 2, 2026 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +175 days, USPTO patent term adjustment record | Oct 24, 2026 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 8,008,449, US 8,779,105, US 9,492,539) | resolves to Oct 24, 2026, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 2 maintenance fees paid | term ended | High confidence |
| Computed term end | The steps above, in order | Oct 24, 2026 | High confidence |
This family
| US 8,008,449 | In force Dec 2028 | Dec 2028 |
| US 8,779,105 | In force Jun 2027 | Jun 2027 |
| US 9,358,289 | Term ended May 2026 | May 2026 |
| US 9,387,247 | this patent Oct 2026 | Oct 2026 |
| US 9,492,539 | Term ended Oct 2026 | Oct 2026 |
| US 9,492,540 | Term ended May 2026 | May 2026 |
| US 9,084,776 | Term ended May 2026 | May 2026 |
| US 10,441,655 | In force May 2027 | May 2027 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jun 10, 2014 Reel 33069, frame 61 | Korman, Alan J.; Srinivasan, Mohan; Wang, Changyu; Selby, Mark J.; Chen, Bing; Cardarelli, Josephine M. | Medarex, Inc. | Assignment of Assignor's Interest |
| Jun 10, 2014 Reel 33069, frame 339 | Huang, Haichun | Medarex, Inc. | Assignment of Assignor's Interest |
| Jun 10, 2014 Reel 33124, frame 53 | Medarex, Inc. | Ono Pharmaceutical Co., Ltd. | Assignment of Undivided 50% of Assignor's Interest |
| Jun 11, 2014 Reel 33080, frame 678 | Medarex, Inc. | Medarex, L.l.c. | Merger |
| Nov 7, 2014 Reel 34126, frame 342 | Medarex, L.l.c. | E. R. Squibb & Sons, L.L.C. | Merger |
| Feb 4, 2015 Reel 34905, frame 592 | Korman, Alan J.; Srinivasan, Mohan; Wang, Changyu; Selby, Mark J.; Chen, Bingliang; Cardarelli, Josephine M. | Medarex, Inc. | Corrective Assignment to Correct the Incorrect Spelling of Inventor "Bing Chen" to "Bingliang Chen" Previously Recorded on Reel 033069 Frame 0061. Assignor(S) Hereby Confirms the Correct Spelling of Inventor as "Bingliang Chen". |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer resolved from the filed document, referencing US 8,008,449, US 8,779,105, US 9,492,539, ends no earlier than this term, so it caps nothing.